Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 04-2005 | 01-2005 | 10-2004 | 07-2004 | 04-2004 | |
| Sales | 2,533 | 6,783 | 2,431 | 0 | 4,155 |
| Cost of Goods | 1,170 | 2,096 | 1,024 | N/A | 1,083 |
| Gross Profit | 1,363 | 4,688 | 1,407 | N/A | 3,072 |
| Operating Expenses | 1,207 | 776 | 442 | 0 | 448 |
| Operating Income | 326 | 4,007 | 989 | N/A | 2,707 |
| Pre-tax Income | 326 | 4,007 | 989 | 0 | 2,707 |
| Income Tax | -34 | 50 | 21 | N/A | 40 |
| Net Income Continuous | 360 | 3,957 | 968 | N/A | 2,667 |
| Net Income | $360 | $3,957 | $968 | $N/A | $2,667 |
| EPS Basic Total Ops | 0.05 | 0.60 | 0.15 | N/A | 0.43 |
| EPS Basic Continuous Ops | 0.05 | 0.60 | 0.15 | N/A | 0.43 |
| EPS Diluted Total Ops | 0.05 | 0.54 | 0.14 | N/A | 0.42 |
| EPS Diluted Continuous Ops | 0.05 | 0.54 | 0.14 | N/A | 0.42 |
| EBITDA(a) | $334 | $4,025 | $1,020 | $N/A | $2,721 |